Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2017

Mar 2, 2017

29995_dirs_2017-03-02_49ffe991-812e-4c29-9e25-852ab310cd4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-02-28

Reporting Person: Hele John C.R. (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-28 Common Stock A 11988 $52.44 Acquired 51770 Direct
2017-02-28 Common Stock F 5277 $52.44 Disposed 46493 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-28 Employee Stock Option (Right to Buy) $52.44 A 42907 Acquired 2027-02-27 Common Stock (42907) Direct
2017-02-28 Restricted Stock Units $ A 14303 Acquired Common Stock (14303) Direct

Footnotes

F1: Shares acquired from the payout of 2014-2016 Performance Shares following determination of the performance factor for such award.

F2: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout.

F3: The options become exercisable in three equal installments on February 28, 2018, 2019, and 2020.

F4: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.

F5: The Restricted Stock Units vest in three equal installments on the first business day in March 2018, 2019 and 2020.